Ontology highlight
ABSTRACT:
OTHER RELATED OMICS DATASETS IN: PRJNA213744PRJNA213380PRJNA214321
PROVIDER: EGAD00001000697 | EGA |
REPOSITORIES: EGA
Jones David T W DT Jäger Natalie N Kool Marcel M Zichner Thomas T Hutter Barbara B Sultan Marc M Cho Yoon-Jae YJ Pugh Trevor J TJ Hovestadt Volker V Stütz Adrian M AM Rausch Tobias T Warnatz Hans-Jörg HJ Ryzhova Marina M Bender Sebastian S Sturm Dominik D Pleier Sabrina S Cin Huriye H Pfaff Elke E Sieber Laura L Wittmann Andrea A Remke Marc M Witt Hendrik H Hutter Sonja S Tzaridis Theophilos T Weischenfeldt Joachim J Raeder Benjamin B Avci Meryem M Amstislavskiy Vyacheslav V Zapatka Marc M Weber Ursula D UD Wang Qi Q Lasitschka Bärbel B Bartholomae Cynthia C CC Schmidt Manfred M von Kalle Christof C Ast Volker V Lawerenz Chris C Eils Jürgen J Kabbe Rolf R Benes Vladimir V van Sluis Peter P Koster Jan J Volckmann Richard R Shih David D Betts Matthew J MJ Russell Robert B RB Russell Robert B RB Coco Simona S Tonini Gian Paolo GP Schüller Ulrich U Hans Volkmar V Graf Norbert N Kim Yoo-Jin YJ Monoranu Camelia C Roggendorf Wolfgang W Unterberg Andreas A Herold-Mende Christel C Milde Till T Kulozik Andreas E AE von Deimling Andreas A Witt Olaf O Maass Eberhard E Rössler Jochen J Ebinger Martin M Schuhmann Martin U MU Frühwald Michael C MC Hasselblatt Martin M Jabado Nada N Rutkowski Stefan S von Bueren André O AO Williamson Dan D Clifford Steven C SC McCabe Martin G MG Collins V Peter VP Wolf Stephan S Wiemann Stefan S Lehrach Hans H Brors Benedikt B Scheurlen Wolfram W Felsberg Jörg J Reifenberger Guido G Northcott Paul A PA Taylor Michael D MD Meyerson Matthew M Pomeroy Scott L SL Yaspo Marie-Laure ML Korbel Jan O JO Korshunov Andrey A Eils Roland R Pfister Stefan M SM Lichter Peter P
Nature 20120801 7409
Medulloblastoma is an aggressively growing tumour, arising in the cerebellum or medulla/brain stem. It is the most common malignant brain tumour in children, and shows tremendous biological and clinical heterogeneity. Despite recent treatment advances, approximately 40% of children experience tumour recurrence, and 30% will die from their disease. Those who survive often have a significantly reduced quality of life. Four tumour subgroups with distinct clinical, biological and genetic profiles ar ...[more]